Inaugural Meeting — November 1, 2024
Our first in-person gathering took place in Madrid (Spain) during the CTAD 2024 Conference. This inaugural meeting brought together representatives from emerging and established Alzheimer’s clinical trial centers across China and worldwide.
Meeting Participants
- Paul Aisen, MD, ATRI, University of Southern California (USC) - San Diego (United States)
- Sandrine Andrieu, MD, PhD, INSERM U 1295, IHU HealthAge, Toulouse (France)
- Piu Chan, MD, PhD, Xuanwu Hospital of Capital University, Beijing Institute of Geriatrics (BIG, Beijing (China)
- Qidong Chen, MD, PhD, Beijing Tiantan Hospital, Capital Medical University, Beijing (China)
- Yolanda Chen, Eli Lilly & Company, Shanghai (China)
- Wei Chen, MD, PhD, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Beijing (China)
- Qin Chen, MD, PhD, West China Hospital, Sichuan University, Chengdu City (China)
- Jeffrey Cummings, MD, PhD, University of Las Vegas Nevada, Las Vegas (United States)
- Linbi Dai, PhD, The First Affiliated Hospital of USTC, Hefei City, Anhui Province (China)
- Ding Ding, PhD, Institute of Neurology, Fudan University, Huashan Hospital Shanghai (China)
- Yifeng Du, MD, PhD, Shandong Provincial Hospital, 324, Jinan City, Shandong Province (China)
- Frank Jessen, MD, PhD, University of Cologne, Medical Faculty, Cologne (Germany)
- Tengfei Guo, PhD, Institute of Biomedical Engineering,Peking University, Shenzhen, Guangdong (China)
- Yanqing Han, MD, PhD, Shanxi Cardiovascular Hospital, Taiyuan City, Shanxi Province (China)
- Longfei Jia, MD, PhD, Xuanwu Hospital, Capital Medical University, Xicheng District, Beijing (China)
- Rena Li, MD, Beijing Institute of Brain Disorders, Capital Medical University, Beijing (China)
- Valerie Legrand, ICON plc, Paris (France)
- Shen Lu, MD, PhD, Xiangya Hospital of Central South University, Changsha City, Hunan Province (China)
- Lefkos Middleton, MD, PhD, Imperial College London, London (United Kingdom)
- Xiaodong Pan, MD, PhD, Fujian Medical University Union Hospital, Fuzhou City, Fujian Province (China)
- Guoping Peng, MD, PhD, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province (China)
- Robert Perneczky, MD, PhD, Alzheimer Therapy and Research Center (ATRC), LMU Hospital,
Munich (Germany)
- Yong Shen, PhD, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei City, Anhui Province (China)
- Jiong Shi, MD, PhD, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei City, Anhui Province (China)
|
- Yi Sui, MD, PhD, Shenyang First People’s Hospital, Shenyang City, Liaoning Province (China)
- Li Sun, MD, PhD, The First Bethune Hospital of Jilin University, Changchun City, Jilin Province (China)
- Gilles Tamagnan, PhD, MITRO, Shanghai (China)
- Huidong Tang, MD, PhD, Rui Jin Hospital, Huangpu District, Shanghai (China)
- Yi Tang, MD, PhD, Xuanwu Hospital, Capital Medical University, Beijing (China)
- Jacques Touchon, MD, PhD, Montpellier University Hospital, Montpellier, (France)
- Bruno Vellas, MD, PhD, IHU HealthAge, Toulouse (France)
- Fei Wang, MD, PhD, Huangshan City People’s Hospital, Huangshan City, Anhui Province (China)
- Bo Wang, MD, PhD, Shanghai Medical Innovation and Development Foundation, - Hongkou District, Shanghai (China)
- Gang Wang, MD, PhD, Renji Hospital affiliated Medical School of Shanghai Jiao Tong University, Shanghai (China)
- Huali Wang, MD, PhD, Chinese Institute for Brain Research, Beijing (China)
- Qiong Wang, MD, PhD, Institute on Aging and Brain Disorders and Department of Neurology The First Affiliated Hospital of USTC, Hefei City, Anhui Province (China)
- Yan-Jiang Wang, MD, PhD, Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Chongqing (China)
- Cuibai Wei, MD, Xuanwu Hospital, Capital Medical University, Beijing (China)
- Michael Weiner, MD, UCSF, San Francisco (United States)
- Bengt Winblad, MD, PhD, Karolinska Institute, Stockholm (Sweden)
- Hui Wu, PhD, Jilin University, Changchun City, Jilin Province (China)
- Xiaohua Xiao, MD, PhD, Shenzhen Second People’s Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen (China)
- Fang Xie, PhD, Huashan Hospital, Fudan University, Shanghai (China)
- Jun Xu, MD, PhD, Beijing Tiantan Hospital, Capital Medical University China National Clinical Research Center for Neurological Diseases, Beijing (China)
- Yun Xu, MD, PhD, Nanjing Drum Tower Hospital and Nanjing University Medical School, Nanjing, Jiangsu (China)
- Jin-Tai Yu, MD, PhD, Huashan Hospital, Fudan University, Shanghai (China)
- Zhentao Zhang, MD, PhD, Renmin Hospital of Wuhan University, Wuhan City, Hubei Province (China)
- Nan Zhang, MD, PhD, Tianjin Medical University General Hospital, Tianjin (China)
- Jiewen Zhang, MD, PhD, Henan Provincial People’s Hospital, Zhengzhou City, Henan Province (China)
- Qinge Zhang, MD, PhD, Beijing Anding Hospital, Capital Medical University, Xicheng District, Beijing (China)
- Yingchun Zhang, MD, PhD, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang (China)
- Xinyu Zhao, MD, PhD, The First Affiliated Hospital of Zhengzhou University, Medical School of Zhengzhou University, Zhengzhou, Henan (China)
- Kate Zhong, MD, CNS Innovation, Las Vegas (United States)
|
|